|
1
|
Chugh SS, Havmoeller R, Narayanan K, Singh
D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr,
Zheng ZJ, et al: Worldwide epidemiology of atrial fibrillation: A
Global Burden of Disease 2010 Study. Circulation. 129:837–847.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Go AS, Hylek EM, Phillips KA, Chang Y,
Henault LE, Selby JV and Singer DE: Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management
and stroke prevention, the AnTicoagulation and Risk Factors in
Atrial Fibrillation (ATRIA) Study. JAMA. 285:2370–2375. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wolf PA, Abbott RD and Kannel WB: Atrial
fibrillation as an independent risk factor for stroke, The
Framingham Study. Stroke. 22:983–988. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Benjamin EJ, Wolf PA, D'Agostino RB,
Silbershatz H, Kannel WB and Levy D: Impact of atrial fibrillation
on the risk of death, The Framingham Heart Study. Circulation.
98:946–952. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim MH, Johnston SS, Chu BC, Dalal MR and
Schulman KL: Estimation of total incremental health care costs in
patients with atrial fibrillation in the United States. Circ
Cardiovasc Qual Outcomes. 4:313–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schnabel RB, Sullivan LM, Levy D, Pencina
MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF,
Magnani JW, Tadros TM, et al: Development of a risk score for
atrial fibrillation (Framingham Heart Study): A community-based
cohort study. Lancet. 373:739–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lubitz SA, Ozcan C, Magnani JW, Kääb S,
Benjamin EJ and Ellinor PT: Genetics of atrial fibrillation,
Implications for future research directions and personalized
medicine. Circ Arrhythm Electrophysiol. 3:291–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brugada R, Tapscott T, Czernuszewicz GZ,
Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A,
Bachinski LL, et al: Identification of a genetic locus for familial
atrial fibrillation. N Engl J Med. 336:905–911. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lubitz SA, Yin X, Fontes JD, Magnani JW,
Rienstra M, Pai M, Villalon ML, Vasan RS, Pencina MJ, Levy D, et
al: Association between familial atrial fibrillation and risk of
new-onset atrial fibrillation. JAMA. 304:2263–2269. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mahida S and Ellinor PT: New advances in
the genetic basis of atrial fibrillation. J Cardiovasc
Electrophysiol. 23:1400–1406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ellinor PT, Lunetta KL, Albert CM, Glazer
NL, Ritchie MD, Smith AV, Arking DE, Müller-Nurasyid M, Krijthe BP,
Lubitz SA, et al: Meta-analysis identifies six new susceptibility
loci for atrial fibrillation. Nat Genet. 44:670–675. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schunkert H, König IR, Kathiresan S,
Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M,
Gieger C, et al: Cardiogenics; CARDIoGRAM Consortium: Large-scale
association analysis identifies 13 new susceptibility loci for
coronary artery disease. Nat Genet. 43:333–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deloukas P, Kanoni S, Willenborg C,
Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D,
Erdmann J, Goldstein BA, et al: CARDIoGRAMplusC4D Consortium;
DIAGRAM Consortium; CARDIOGENICS Consortium; MuTHER Consortium;
Wellcome Trust Case Control Consortium: Large-scale association
analysis identifies new risk loci for coronary artery disease. Nat
Genet. 45:25–33. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsuoka R, Abe S, Tokoro F, Arai M, Noda
T, Watanabe S, Horibe H, Fujimaki T, Oguri M, Kato K, et al:
Association of six genetic variants with myocardial infarction. Int
J Mol Med. 35:1451–1459. 2015.PubMed/NCBI
|
|
15
|
Yamada Y, Nishida T, Ichihara S, Sawabe M,
Fuku N, Nishigaki Y, Aoyagi Y, Tanaka M, Fujiwara Y, Yoshida H, et
al: Association of a polymorphism of BTN2A1 with myocardial
infarction in East Asian populations. Atherosclerosis. 215:145–152.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamada Y, Nishida T, Ichihara S, Kato K,
Fujimaki T, Oguri M, Horibe H, Yoshida T, Watanabe S, Satoh K, et
al: Identification of chromosome 3q28 and ALPK1 as susceptibility
loci for chronic kidney disease in Japanese individuals by a
genome-wide association study. J Med Genet. 50:410–418. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Itoh Y, Mizuki N, Shimada T, Azuma F,
Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M and Inoko H:
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a
PCR-SSOP-Luminex method in the Japanese population. Immunogenetics.
57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jang CY and Fang G: The N-terminal domain
of DDA3 regulates the spindle-association of the microtubule
depolymerase Kif2a and controls the mitotic function of DDA3. Cell
Cycle. 8:3165–3171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Musunuru K, Strong A, Frank-Kamenetsky M,
Lee NE, Ahfeldt T, Sachs KV, Li X, Li H, Kuperwasser N, Ruda VM, et
al: From noncoding variant to phenotype via SORT1 at the 1p13
cholesterol locus. Nature. 466:714–719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Samani NJ, Erdmann J, Hall AS,
Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund
P, Wichmann HE, et al: WTCCC and the Cardiogenics Consortium:
Genomewide association analysis of coronary artery disease. N Engl
J Med. 357:443–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Linsel-Nitschke P, Heeren J, Aherrahrou Z,
Bruse P, Gieger C, Illig T, Prokisch H, Heim K, Doering A, Peters
A, et al: Genetic variation at chromosome 1p13.3 affects sortilin
mRNA expression, cellular LDL-uptake and serum LDL levels which
translates to the risk of coronary artery disease. Atherosclerosis.
208:183–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fujimaki T, Oguri M, Horibe H, Kato K,
Matsuoka R, Abe S, Tokoro F, Arai M, Noda T, Watanabe S, et al:
Association of a transcription factor 21 gene polymorphism with
hypertension. Biomed Rep. 3:118–122. 2015.PubMed/NCBI
|
|
23
|
Abe S, Tokoro F, Matsuoka R, Arai M, Noda
T, Watanabe S, Horibe H, Fujimaki T, Oguri M, Kato K, et al:
Association of genetic variants with dyslipidemia. Mol Med Rep.
12:5429–5436. 2015.PubMed/NCBI
|
|
24
|
Ouyang T, Bai RY, Bassermann F, von
Klitzing C, Klumpen S, Miething C, Morris SW, Peschel C and Duyster
J: Identification and characterization of a nuclear interacting
partner of anaplastic lymphoma kinase (NIPA). J Biol Chem.
278:30028–30036. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klitzing C, Huss R, Illert AL, Fröschl A,
Wötzel S, Peschel C, Bassermann F and Duyster J:
APC/C(Cdh1)-mediated degradation of the F-box protein NIPA is
regulated by its association with Skp1. PLoS One. 6:e289982011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li R and Morris SW: Development of
anaplastic lymphoma kinase (ALK) small-molecule inhibitors for
cancer therapy. Med Res Rev. 28:372–412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
López-Mejías R, Corrales A, Genre F,
Hernández JL, Ochoa R, Blanco R, González-Juanatey C, Martín J,
Llorca J and González-Gay MA: Angiopoietin-2 serum levels correlate
with severity, early onset and cardiovascular disease in patients
with rheumatoid arthritis. Clin Exp Rheumatol. 31:761–766.
2013.PubMed/NCBI
|
|
28
|
López-Mejías R, Genre F, García-Bermúdez
M, Corrales A, González-Juanatey C, Llorca J, Miranda-Filloy JA,
Rueda-Gotor J, Blanco R, Castañeda S, et al: The ZC3HC1
rs11556924 polymorphism is associated with increased carotid
intima-media thickness in patients with rheumatoid arthritis.
Arthritis Res Ther. 15:R1522013. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Neal WT, Efird JT, Yeboah J, Nazarian S,
Alonso A, Heckbert SR and Soliman EZ: Brachial flow-mediated
dilation and incident atrial fibrillation, The multi-ethnic study
of atherosclerosis. Arterioscler Thromb Vasc Biol. 34:2717–2720.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Skalidis EI, Zacharis EA, Tsetis DK,
Pagonidis K, Chlouverakis G, Yarmenitis S, Hamilos M, Manios EG and
Vardas PE: Endothelial cell function during atrial fibrillation and
after restoration of sinus rhythm. Am J Cardiol. 99:1258–1262.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim YM, Guzik TJ, Zhang YH, Zhang MH,
Kattach H, Ratnatunga C, Pillai R, Channon KM and Casadei B: A
myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative
stress in human atrial fibrillation. Circ Res. 97:629–636. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haïssaguerre M, Jaïs P, Shah DC, Takahashi
A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P and
Clémenty J: Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary veins. N Engl J Med.
339:659–666. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heeringa J, van der Kuip DA, Hofman A,
Kors JA, van Rooij FJ, Lip GY and Witteman JC: Subclinical
atherosclerosis and risk of atrial fibrillation: The rotterdam
study. Arch Intern Med. 167:382–387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Casaclang-Verzosa G, Gersh BJ and Tsang
TS: Structural and functional remodeling of the left atrium,
Clinical and therapeutic implications for atrial fibrillation. J Am
Coll Cardiol. 51:1–11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Logan M, Pagán-Westphal SM, Smith DM,
Paganessi L and Tabin CJ: The transcription factor Pitx2 mediates
situs-specific morphogenesis in response to left-right asymmetric
signals. Cell. 94:307–317. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Berry FB, Miura Y, Mihara K, Kaspar P,
Sakata N, Hashimoto-Tamaoki T and Tamaoki T: Positive and negative
regulation of myogenic differentiation of C2C12 cells by isoforms
of the multiple homeodomain zinc finger transcription factor ATBF1.
J Biol Chem. 276:25057–25065. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ihida-Stansbury K, McKean DM, Gebb SA,
Martin JF, Stevens T, Nemenoff R, Akeson A, Vaughn J and Jones PL:
Paired-related homeobox gene Prx1 is required for pulmonary
vascular development. Circ Res. 94:1507–1514. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ellinor PT, Lunetta KL, Glazer NL, Pfeufer
A, Alonso A, Chung MK, Sinner MF, de Bakker PI, Mueller M, Lubitz
SA, et al: Common variants in KCNN3 are associated with lone atrial
fibrillation. Nat Genet. 42:240–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gretarsdottir S, Thorleifsson G, Manolescu
A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, Kostulas K,
Kuhlenbäumer G, Bevan S, Jonsdottir T, et al: Risk variants for
atrial fibrillation on chromosome 4q25 associate with ischemic
stroke. Ann Neurol. 64:402–409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gudbjartsson DF, Holm H, Gretarsdottir S,
Thorleifsson G, Walters GB, Thorgeirsson G, Gulcher J, Mathiesen
EB, Njølstad I, Nyrnes A, et al: A sequence variant in ZFHX3 on
16q22 associates with atrial fibrillation and ischemic stroke. Nat
Genet. 41:876–878. 2009. View
Article : Google Scholar : PubMed/NCBI
|
